Consensus EPS · Q2 2026
-$0.18
Consensus revenue · Q2 2026
$193.6M
Analysts
6
Expected report
Aug 12, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 6 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $188.3M | $193.6M | $196.1M |
| EPS | -$0.29 | -$0.18 | -$0.14 |
| EBITDA | -$116.9M | -$116.8M | -$116.7M |
| EBIT | -$120.2M | -$120.1M | -$120M |
| Net income | -$11.4M | -$10.8M | -$10.6M |
- Revenue$193.6M
- EPS-$0.18
- EBITDA-$116.8M
- EBIT-$120.1M
- Net income-$10.8M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $191.3M | $181.2M | +5.6% | -$0.04 | -$0.16 | +75.6% |
- Q1 2026+5.6%+75.6%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $180.7M | $180.7M | — | — | 0% |
| EPS | -$0.37 | -$0.37 | — | — | 0% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Cerebras Systems (CBRS) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 1 analyst.
- Low
- $273.00
- Consensus
- $298.50
- Median
- $300.00
- High
- $325.00
- Current
- $198.71
- Upside
- +50.2%
Upside calculated vs most recent trading price of $198.71.
Analyst ratings
Consensus: Buy — based on 6 analyst ratings.
2-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 27, 2026 | Mizuho | maintain | Outperform | Outperform |
| Jun 24, 2026 | Wedbush | maintain | Outperform | Outperform |
| Jun 24, 2026 | UBS | maintain | Buy | Buy |
| Jun 24, 2026 | Rosenblatt | maintain | Buy | Buy |
| Jun 24, 2026 | Needham | maintain | Buy | Buy |
| Jun 24, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
- Jul 27, 2026MizuhoOutperform
- Jun 24, 2026WedbushOutperform
- Jun 24, 2026UBSBuy
- Jun 24, 2026RosenblattBuy
- Jun 24, 2026NeedhamBuy
- Jun 24, 2026Morgan StanleyOverweight
Frequently asked questions
Cerebras Systems (CBRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.